Cardiff Lexington Signs $104M M&A Deal with multi-location musculoskeletal healthcare platform
Cardiff Lexington Corporation has entered into a letter of intent to acquire a multi-location musculoskeletal healthcare platform for up to $104 million. The deal structure includes $30 million in cash, $10 million in notes, and preferred equity representing 35% of the company, plus $12 million in performance-based stock. The acquisition is intended to create a cornerstone regional healthcare platform and expand the company's orthopedic and spine care operations.
- Value
- $104M
- Counterparty
- multi-location musculoskeletal healthcare platform